Have a personal or library account? Click to login
New-Onset Movement Disorders Associated with COVID-19 Cover

New-Onset Movement Disorders Associated with COVID-19

Tremor and Other Hyperkinetic Movements
Volume 11 (2021): Issue 1
By: Pedro Renato P. Brandão,  Talyta C. Grippe,  Danilo A. Pereira,  Renato P. Munhoz and  Francisco Cardoso  
Open Access
|Jul 2021

References

  1. 1Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019. JAMA Neurology. 2020; 77(8). DOI: 10.1001/jamaneurol.2020.2065
    Back to article
  2. 2Munhoz RP, Pedroso JL, Nascimento FA, et al. Neurological complications in patients with SARS-CoV-2 infection: A systematic review. Arquivos de Neuro-Psiquiatria. 2020; 78(5): 290–300. DOI: 10.1590/0004-282x20200051
    Back to article
  3. 3Romero-Sánchez CM, Díaz-Maroto I, Fernández-Díaz E, et al. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry. Neurology. 2020; 95(8). DOI: 10.1212/WNL.0000000000009937
    Back to article
  4. 4Studart-Neto A, Guedes BF, Tuma RL, et al. Neurological consultations and diagnoses in a large, dedicated COVID-19 university hospital. Arquivos de Neuro-Psiquiatria. 2020; 78(8). DOI: 10.1590/0004-282x20200089
    Back to article
  5. 5Bürkner P-C. brms: An R Package for Bayesian Multilevel Models Using Stan. Journal of Statistical Software. 2017; 80(1). DOI: 10.18637/jss.v080.i01
    Back to article
  6. 6Stan Development Team. Stan Modeling Language Users Guide and Reference Manual, 2.26. https://mc-stan.org.
    Back to article
  7. 7Gabry J, Simpson D, Vehtari A, Betancourt M, Gelman A. Visualization in Bayesian workflow. Journal of the Royal Statistical Society: Series A (Statistics in Society). 2019; 182(2). DOI: 10.1111/rssa.12378
    Back to article
  8. 8Charrad M, Ghazzali N, Boiteau V, Niknafs A. NbClust: An R Package for Determining the Relevant Number of Clusters in a Data Set. Journal of Statistical Software. 2014; 61(6). DOI: 10.18637/jss.v061.i06
    Back to article
  9. 9Schubert E, Rousseeuw PJ. Faster k-Medoids Clustering: Improving the PAM, CLARA, and CLARANS Algorithms. In: Amato G, Gennaro C, Oria V, Radovanović M, (eds.) Vol 11807. Lecture Notes in Computer Science, 171–187. Springer International Publishing; 2019. DOI: 10.1007/978-3-030-32047-8_16
    Back to article
  10. 10Faber I, Brandão PRP, Menegatti F, Carvalho Bispo DD, Maluf FB, Cardoso F. Coronavirus Disease 2019 and Parkinsonism: A Non-post-encephalitic Case. Movement Disorders. 2020; 35(10). DOI: 10.1002/mds.28277
    Back to article
  11. 11Méndez-Guerrero A, Laespada-García MI, Gómez-Grande A, et al. Acute hypokinetic-rigid syndrome following SARS-CoV-2 infection. Neurology. 2020; 95(15). DOI: 10.1212/WNL.0000000000010282
    Back to article
  12. 12Piscitelli D, Perin C, Tremolizzo L, Peroni F, Cerri CG, Cornaggia CM. Functional movement disorders in a patient with COVID-19. Neurological Sciences. 2020; 41(9). DOI: 10.1007/s10072-020-04593-1
    Back to article
  13. 13Mas Serrano M, Pérez-Sánchez JR, Portela Sánchez S, et al. Serotonin syndrome in two COVID-19 patients treated with lopinavir/ritonavir. Journal of the Neurological Sciences. 2020; 415. DOI: 10.1016/j.jns.2020.116944
    Back to article
  14. 14Rábano-Suárez P, Bermejo-Guerrero L, Méndez-Guerrero A, et al. Generalized myoclonus in COVID-19. Neurology. 2020; 95(6). DOI: 10.1212/WNL.0000000000009829
    Back to article
  15. 15Cuhna P, Herlin B, Vassilev K, et al. Movement disorders as a new neurological clinical picture in severe SARS-CoV-2 infection. European Journal of Neurology. 2020; 27(12). DOI: 10.1111/ene.14474
    Back to article
  16. 16Paterson RW, Brown RL, Benjamin L, et al. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain. 2020; 143(10). DOI: 10.1093/brain/awaa240
    Back to article
  17. 17Chaumont H, San-Galli A, Martino F, et al. Mixed central and peripheral nervous system disorders in severe SARS-CoV-2 infection. Journal of Neurology. 2020; 267(11). DOI: 10.1007/s00415-020-09986-y
    Back to article
  18. 18Dijkstra F, van den Bossche T, Willekens B, Cras P, Crosiers D. Myoclonus and Cerebellar Ataxia Following COVID-19. Movement Disorders Clinical Practice. 2020; 7(8). DOI: 10.1002/mdc3.13049
    Back to article
  19. 19Gutiérrez-Ortiz C, Méndez-Guerrero A, Rodrigo-Rey S, et al. Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020; 95(5). DOI: 10.1212/WNL.0000000000009619
    Back to article
  20. 20Lantos JE, Strauss SB, Lin E. COVID-19–Associated Miller Fisher Syndrome: MRI Findings. American Journal of Neuro-radiology. 2020; 41(7). DOI: 10.3174/ajnr.A6609
    Back to article
  21. 21Balestrino R, Rizzone M, Zibetti M, et al. Onset of Covid-19 with impaired consciousness and ataxia: a case report. Journal of Neurology. 2020; 267(10). DOI: 10.1007/s00415-020-09879-0
    Back to article
  22. 22Mao L, Jin H, Wang M, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurology. 2020; 77(6). DOI: 10.1001/jamaneurol.2020.1127
    Back to article
  23. 23Fadakar N, Ghaemmaghami S, Masoompour SM, et al. A First Case of Acute Cerebellitis Associated with Coronavirus Disease (COVID-19): a Case Report and Literature Review. The Cerebellum. 2020; 19(6). DOI: 10.1007/s12311-020-01177-9
    Back to article
  24. 24Xiong W, Mu J, Guo J, et al. New onset neurologic events in people with COVID-19 in 3 regions in China. Neurology. 2020; 95(11). DOI: 10.1212/WNL.0000000000010034
    Back to article
  25. 25Klein S, Davis F, Berman A, Koti S, D’Angelo J, Kwon N. A Case Report of Coronavirus Disease 2019 Presenting with Tremors and Gait Disturbance. Clinical Practice and Cases in Emergency Medicine. 2020; 4(3). DOI: 10.5811/cpcem.2020.5.48023
    Back to article
  26. 26Cohen ME, Eichel R, Steiner-Birmanns B, et al. A case of probable Parkinson’s disease after SARS-CoV-2 infection. The Lancet Neurology. 2020; 19(10). DOI: 10.1016/S1474-4422(20)30305-7
    Back to article
  27. 27Sanguinetti S, Ramdhani RA. Opsoclonus Myoclonus Ataxia Syndrome Related to the Novel Coronavirus (COVID-19). Journal of Neuro-Ophthalmology. 2020; Ahead of Print. DOI: 10.1097/WNO.0000000000001129
    Back to article
  28. 28Ros-Castelló V, Quereda C, López-Sendón J, Corral I. Post-Hypoxic Myoclonus after COVID-19 Infection Recovery. Movement Disorders Clinical Practice. 2020; 7(8). DOI: 10.1002/mdc3.13025
    Back to article
  29. 29Wright D, Rowley R, Halks-Wellstead P, Anderson T, Wu TY. Abnormal Saccadic Oscillations Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Encephalopathy and Ataxia. Movement Disorders Clinical Practice. 2020; 7(8). DOI: 10.1002/mdc3.13101
    Back to article
  30. 30Muccioli L, Rondelli F, Ferri L, Rossini G, Cortelli P, Guarino M. Subcortical Myoclonus in Coronavirus Disease 2019: Comprehensive Evaluation of a Patient. Movement Disorders Clinical Practice. 2020; 7(8). DOI: 10.1002/mdc3.13046
    Back to article
  31. 31Borroni B, Gazzina S, Dono F, et al. Diaphragmatic myoclonus due to SARS-CoV-2 infection. Neurological Sciences. 2020; 41(12). DOI: 10.1007/s10072-020-04766-y
    Back to article
  32. 32Schellekens MMI, Bleeker-Rovers CP, Keurlings PAJ, Mummery CJ, Bloem BR. Reversible Myoclonus-Ataxia as a Postinfectious Manifestation of COVID-19. Movement Disorders Clinical Practice. 2020; 7(8). DOI: 10.1002/mdc3.13088
    Back to article
  33. 33Anand P, Zakaria A, Benameur K, et al. Myoclonus in Patients With Coronavirus Disease 2019: A Multicenter Case Series. Critical Care Medicine. 2020; 48(11). DOI: 10.1097/CCM.0000000000004570
    Back to article
  34. 34Grimaldi S, Lagarde S, Harlé J-R, Boucraut J, Guedj E. Autoimmune Encephalitis Concomitant with SARS-CoV-2 Infection: Insight from 18 F-FDG PET Imaging and Neuronal Autoantibodies. Journal of Nuclear Medicine. 2020; 61(12). DOI: 10.2967/jnumed.120.249292
    Back to article
  35. 35Byrnes S, Bisen M, Syed B, et al. COVID-19 encephalopathy masquerading as substance withdrawal. Journal of Medical Virology. 2020; 92(11). DOI: 10.1002/jmv.26065
    Back to article
  36. 36Kopscik M, Giourgas B, Presley B. A Case Report of Acute Motor and Sensory Polyneuropathy as the Presenting Symptom of SARS-CoV-2. Clinical Practice and Cases in Emergency Medicine. 2020; 4(3). DOI: 10.5811/cpcem.2020.6.48683
    Back to article
  37. 37Fernández-Domínguez J, Ameijide-Sanluis E, García-Cabo C, García-Rodríguez R, Mateos V. Miller–Fisher-like syndrome related to SARS-CoV-2 infection (COVID-19). Journal of Neurology. 2020; 267(9). DOI: 10.1007/s00415-020-09912-2
    Back to article
  38. 38Dinkin M, Gao V, Kahan J, et al. COVID-19 presenting with ophthalmoparesis from cranial nerve palsy. Neurology. 2020; 95(5). DOI: 10.1212/WNL.0000000000009700
    Back to article
  39. 39Perrin P, Collongues N, Baloglu S, et al. Cytokine release syndrome-associated encephalopathy in patients with COVID-19. European Journal of Neurology. 2021; 28(1). DOI: 10.1111/ene.14491
    Back to article
  40. 40Hayashi M, Sahashi Y, Baba Y, Okura H, Shimohata T. COVID-19-associated mild encephalitis/encephalopathy with a reversible splenial lesion. Journal of the Neurological Sciences. 2020; 415. DOI: 10.1016/j.jns.2020.116941
    Back to article
  41. 41Khoo A, McLoughlin B, Cheema S, et al. Postinfectious brainstem encephalitis associated with SARS-CoV-2. Journal of Neurology, Neurosurgery & Psychiatry. 2020; 91(9). DOI: 10.1136/jnnp-2020-323816
    Back to article
  42. 42Pilotto A, Odolini S, Masciocchi S, et al. Steroid-Responsive Encephalitis in Coronavirus Disease 2019. Annals of Neurology. 2020; 88(2). DOI: 10.1002/ana.25783
    Back to article
  43. 43Delorme C, Paccoud O, Kas A, et al. COVID-19 related encephalopathy: a case series with brain FDG-positron-emission tomography/computed tomography findings. European Journal of Neurology. 2020; 27(12). DOI: 10.1111/ene.14478
    Back to article
  44. 44Caan MP, Lim CT, Howard M. A Case of Catatonia in a Man With COVID-19. Psychosomatics. 2020; 61(5). DOI: 10.1016/j.psym.2020.05.021
    Back to article
  45. 45Pilotto A, Masciocchi S, Volonghi I, et al. Clinical Presentation and Outcomes of Severe Acute Respiratory Syndrome Coronavirus 2–Related Encephalitis: The ENCOVID Multicenter Study. The Journal of Infectious Diseases. 2021; 223(1). DOI: 10.1093/infdis/jiaa609
    Back to article
  46. 46Povlow A, Auerbach AJ. Acute Cerebellar Ataxia in COVID-19 Infection: A Case Report. The Journal of Emergency Medicine. 2021; 60(1). DOI: 10.1016/j.jemermed.2020.10.010
    Back to article
  47. 47Franke C, Ferse C, Kreye J, et al. High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms. Brain, Behavior, and Immunity. Published online December 2020. DOI: 10.1016/j.bbi.2020.12.022
    Back to article
  48. 48Fernando EZ, Yu JRT, Santos SMA, Jamora RDG. Involuntary Movements Following Administration of Hydroxychloroquine for COVID-19 Pneumonia. Journal of Movement Disorders. 2021; 14(1). DOI: 10.14802/jmd.20091
    Back to article
  49. 49Deocleciano de Araujo C, Schlittler LXC, Sguario RM, Tsukumo DM, Dalgalarrondo P, Banzato CEM. Life-Threatening Catatonia Associated With Coronavirus Disease 2019. Psychosomatics. Published online October 2020. DOI: 10.1016/j.psym.2020.09.007
    Back to article
  50. 50Emamikhah M, Babadi M, Mehrabani M, et al. Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature. Journal of NeuroVirology. 2021; 27(1): 26–34. DOI: 10.1007/s13365-020-00941-1
    Back to article
  51. 51Urrea-Mendoza E, Okafor K, Ravindran S, Absher J, Chaubal V, Revilla FJ. Opsoclonus-myoclonus-ataxia syndrome (Omas) associated with sars-cov-2 infection: Post-infectious neurological complication with benign prognosis. Tremor and Other Hyperkinetic Movements. 2021; 11(1): 1–4. DOI: 10.5334/tohm.580
    Back to article
  52. 52Romero-Sánchez CM, Díaz-Maroto I, Fernández-Díaz E, et al. Neurologic manifestations in hospitalized patients with COVID-19. Neurology. 2020; 95(8). DOI: 10.1212/WNL.0000000000009937
    Back to article
  53. 53Sutter R, Ristic A, Rüegg S, Fuhr P. Myoclonus in the critically ill: Diagnosis, management, and clinical impact. Clinical Neurophysiology. 2016; 127(1): 67–80. DOI: 10.1016/j.clinph.2015.08.009
    Back to article
  54. 54Krewulak KD, Stelfox HT, Leigh JP, Ely EW, Fiest KM. Incidence and Prevalence of Delirium Subtypes in an Adult ICU. Critical Care Medicine. 2018; 46(12): 2029–2035. DOI: 10.1097/CCM.0000000000003402
    Back to article
  55. 55Zutt R, van Egmond ME, Elting JW, et al. A novel diagnostic approach to patients with myoclonus. Nature Reviews Neurology. 2015; 11(12). DOI: 10.1038/nrneurol.2015.198
    Back to article
  56. 56Latorre A, Rothwell JC. Myoclonus and COVID-19: A Challenge for the Present, a Lesson for the Future. Movement Disorders Clinical Practice. 2020; 7(8). DOI: 10.1002/mdc3.13103
    Back to article
  57. 57Reiber H. Cerebrospinal fluid data compilation and knowledge-based interpretation of bacterial, viral, parasitic, oncological, chronic inflammatory and demyelinating diseases. Diagnostic patterns not to be missed in neurology and psychiatry. Arquivos de Neuro-Psiquiatria. 2016; 74(4): 337–350. DOI: 10.1590/0004-282X20160044
    Back to article
  58. 58Brundin P, Nath A, Beckham JD. Is COVID-19 a Perfect Storm for Parkinson’s Disease? Trends in Neurosciences. 2020; 43(12). DOI: 10.1016/j.tins.2020.10.009
    Back to article
  59. 59Reichard RR, Kashani KB, Boire NA, Constantopoulos E, Guo Y, Lucchinetti CF. Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathologica. 2020; 140(1). DOI: 10.1007/s00401-020-02166-2
    Back to article
  60. 60Solomon IH, Normandin E, Bhattacharyya S, et al. Neuropathological Features of COVID-19. New England Journal of Medicine. 2020; 383(10). DOI: 10.1056/NEJMc2019373
    Back to article
  61. 61von Weyhern CH, Kaufmann I, Neff F, Kremer M. Early evidence of pronounced brain involvement in fatal COVID-19 outcomes. The Lancet. 2020; 395(10241). DOI: 10.1016/S0140-6736(20)31282-4
    Back to article
  62. 62Thakur KT, Miller EH, Glendinning MD, et al. COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital. Brain. Published online April 15, 2021. DOI: 10.1093/brain/awab148
    Back to article
  63. 63Geyer HL, Kaufman DM, Parihar RK, Mehler MF. Movement Disorders in COVID-19: Whither Art Thou? Tremor and Other Hyperkinetic Movements. 2020; 10(1). DOI: 10.5334/tohm.553
    Back to article
DOI: https://doi.org/10.5334/tohm.595 | Journal eISSN: 2160-8288
Journal RSS Feed
Language: English
Submitted on: Dec 10, 2020
Accepted on: Jun 29, 2021
Published on: Jul 8, 2021
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
movement disorders,
parkinsonism,
myoclonus,
ataxia,
opsoclonus,
chorea,
COVID-19,
SARS-CoV-2

© 2021 Pedro Renato P. Brandão, Talyta C. Grippe, Danilo A. Pereira, Renato P. Munhoz, Francisco Cardoso, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 11 (2021): Issue 1Next article